Skip to content

Browse Protocols

Wrote one of these methods? Find yours by DOI and review the entry.

Find your method
934 protocols found
934 protocols found
BRAIN
Publication-derived

Schizophrenia Brain Organoids for Disease Modelling (BN-DS-17)

Source Stachowiak et al., 2017 · State University of New York at Buffalo, Department of Pathology and Anatomical Sciences · DOI

Duration: 35 days Cell source: Human ESC (H9, HUES8) and Patient-Derived iPSC (Schizophrenia, Control) Full SOP · 6 phases · QC included
Disease modelling
BN-DS-17 Full SOP with Academic or a plan
ENDOMETRIUM
Publication-derived

Endometrial Cancer Tumouroids for Drug Screening (EM-DS-19)

Source Boretto et al., 2019 · KU Leuven, Laboratory of Tissue Plasticity in Health and Disease · DOI

Duration: 30 days Cell source: Patient-Derived Endometrial Tissue (Healthy and Endometrial Diseases: Endometriosis, Hyperplasia, Endometrial Cancer) Full SOP · 17 phases · QC included
Drug screening
EM-DS-19 Full SOP with Academic or a plan
BRAIN
Publication-derived

Congenital Rubella Syndrome Brain Organoids (BN-DS-23)

Source Popova et al., 2023 · University of California, San Francisco · DOI

Duration: 45 days Cell source: Human iPSC Full SOP · 18 phases · QC included
Disease modelling
BN-DS-23 Full SOP with Academic or a plan
BRAIN
Publication-derived

COVID-19 Cortical Organoids

Source McMahon et al.

Duration: 43 days Cell source: Human ESC (H9) Full SOP · 6 phases · QC included
Disease modelling
Full SOP with Academic or a plan
SKIN
Publication-derived

Skin Organoids for Disease Modelling with Hair Follicles (SK-DS-25)

Source De Henau et al., 2025 · Leiden University Medical Center, Department of Anatomy and Embryology · DOI

Duration: 90 days Cell source: Human iPSC Full SOP · 6 phases · QC included
Disease modelling
SK-DS-25 Full SOP with Academic or a plan
GASTRIC
Publication-derived

Locally Advanced Rectal Cancer Tumouroids (GS-DS-20)

Source Yao et al., 2020 · Fudan University Shanghai Cancer Center, Department of Radiation Oncology · DOI

Duration: 39 days Cell source: Patient-Derived Primary Rectal Cancer Tissue Full SOP · 10 phases · QC included
Drug screening
GS-DS-20 Full SOP with Academic or a plan
BRAIN
Publication-derived

Cortical Organoids for Drug Screening and Development (BN-NT-21)

Source Notaras et al., 2021 · Center for Neurogenetics, Feil Family Brain and Mind Research Institute, Weill Cornell Medical College, Cornell University · DOI

Duration: 48 days Cell source: Human iPSC Full SOP · 10 phases · QC included
Drug screening
BN-NT-21 Full SOP with Academic or a plan
BRAIN
Publication-derived

COVID-19 Brain Organoids for Infection Studies (BN-DS-20)

Source Bullen et al., 2020 · Johns Hopkins University, Bloomberg School of Public Health, Center for Alternatives to Animal Testing (CAAT) · DOI

Duration: 72 days Cell source: Human iPSC (NIBSC-8 and CRL-2097 lines) Full SOP · 6 phases · QC included
Disease modelling
BN-DS-20 Full SOP with Academic or a plan
LIVER
Publication-derived

Liver Organoids for Drug Screening (2023) (LV-DS-23)

Source Wu et al., 2023 · Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences · DOI

Duration: 25 days Cell source: Human iPSC Full SOP · 10 phases · QC included
Drug screening
LV-DS-23 Full SOP with Academic or a plan
BRAIN
Publication-derived

Brain 2D Cell Cultures for Drug Screening (BN-DS-16)

Source Xu et al., 2016 · National Center for Advancing Translational Sciences, National Institutes of Health; Johns Hopkins University School of Medicine; Florida State University · DOI

Duration: 24 days Cell source: Human iPSC-derived forebrain-specific neural progenitor cells (hNPCs) and astrocytes Full SOP · 7 phases · QC included
Drug screening
BN-DS-16 Full SOP with Academic or a plan
KIDNEY
Publication-derived

Kidney Organoids for Disease Modelling with Gene Editing (KD-DS-17)

Source Kim et al., 2017 · University of Washington School of Medicine · DOI

Duration: 18 days Cell source: Human ESC (WA09), Human iPSC (WTC11, NPHS1-GFP 201B7) Full SOP · 7 phases · QC included
Disease modelling
KD-DS-17 Full SOP with Academic or a plan
INTESTINAL
Publication-derived

Intestinal Organoids for Infection Studies (2016) (IN-DS-16)

Source Bartfeld, 2016 · Research Centre for Infectious Diseases, Institute of Molecular Infection Biology, University of Würzburg · DOI

Duration: 28 days Cell source: Human ASC (Adult Stem Cells) and Human iPSC (induced pluripotent stem cells) Full SOP · 9 phases · QC included
Disease modelling
IN-DS-16 Full SOP with Academic or a plan
LIVER
Publication-derived

Liver Organoids for Drug Screening (2017) (LV-DI-17)

Source Sgodda et al., 2017 · Hannover Medical School · DOI

Duration: 21 days Cell source: Human ESC (H9 line) and Human iPSC Full SOP · 5 phases · QC included
Drug screening
LV-DI-17 Full SOP with Academic or a plan
OTHER
Publication-derived

Organoids for Drug Screening

Source Xinaris et al., 2015 · IRCCS – Istituto di Ricerche Farmacologiche 'Mario Negri', Bergamo, Italy · DOI

Duration: 60 days Cell source: Human ESC, Human iPSC, Patient-Derived iPSC Full SOP · 6 phases · QC included
Drug screening
Full SOP with Academic or a plan
INTESTINAL
Publication-derived

Colorectal Cancer Colonic Tumouroids for Biobanking (IN-DS-19)

Source Schnalzger et al., 2019 · Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany · DOI

Duration: 60 days Cell source: Patient-Derived iPSC (colorectal cancer) Full SOP · 8 phases · QC included
Drug screening
IN-DS-19 Full SOP with Academic or a plan
RETINA
Publication-derived

Retinal 2D Cell Cultures for Drug Screening

Source Ohlemacher et al. · Indiana University-Purdue University Indianapolis, Department of Biology · DOI

Duration: 90 days Cell source: Human pluripotent stem cells (hPSCs) Full SOP · 6 phases · QC included
Drug screening
Full SOP with Academic or a plan
INTESTINAL
Publication-derived

COVID-19 Small Intestinal Organoids (IN-DS-20)

Source Zhou et al., 2020 · The University of Hong Kong · DOI

Duration: 72 days Cell source: Human iPSC-derived (pediatric donors) Full SOP · 8 phases · QC included
Disease modelling
IN-DS-20 Full SOP with Academic or a plan
BRAIN
Publication-derived

Fetal Alcohol Spectrum Disorder Cortical Organoids (BN-DS-23)

Source Adams et al., 2023 · University of California San Diego, Department of Pediatrics/Rady Children's Hospital · DOI

Duration: 84 days Cell source: Human iPSC (WT83C6, CVB, 4C1) and primary human fetal neurons (10-11 PCW) Full SOP · 12 phases · QC included
Disease modelling
BN-DS-23 Full SOP with Academic or a plan
BRAIN
Publication-derived

COVID-19 Cortical Assembloids (BN-DS-23)

Source Kong et al., 2023 · Adult Stem Cell Research Center and Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University · DOI

Duration: 71 days Cell source: Human iPSC Full SOP · 4 phases · QC included
Disease modelling
BN-DS-23 Full SOP with Academic or a plan
BRAIN
Publication-derived

Familial Alzheimer's Disease Cortical Organoids (BN-DS-22)

Source Shimada et al., 2022 · Keio University School of Medicine · DOI

Duration: 126 days Cell source: Human iPSC, Patient-Derived iPSC (familial Alzheimer's disease) Full SOP · 7 phases · QC included
Disease modelling
BN-DS-22 Full SOP with Academic or a plan
RETINA
Publication-derived

Retinal Organoids for Disease Modelling with Single-Cell Profiling (RT-DS-19)

Source Kim et al., 2019 · Albert Einstein College of Medicine · DOI

Duration: 270 days Cell source: Human ESC (H1) and Human iPSC Full SOP · 5 phases · QC included
Disease modelling
RT-DS-19 Full SOP with Academic or a plan
BRAIN
Publication-derived

Parkinson's Disease Midbrain Organoids (2020) (BN-DS-20)

Source Kwak et al., 2020 · Konkuk University, Department of Stem Cell Biology, School of Medicine, Seoul, Republic of Korea · DOI

Duration: 20 days Cell source: Human ESC Full SOP · 5 phases · QC included
Disease modelling
BN-DS-20 Full SOP with Academic or a plan
BRAIN
Publication-derived

Autism Spectrum Disorder Cortical Organoids for Disease Modelling (BN-CA-23)

Source Cleveland Clinic · DOI

Duration: 72 days Cell source: Patient-Derived iPSC (PTEN germline mutations: PHTS-ASD and PHTS-cancer) Full SOP · 8 phases · QC included
Disease modelling
BN-CA-23 Full SOP with Academic or a plan
GASTRIC
Publication-derived

Locally Advanced Rectal Cancer Tumouroids for Drug Screening (GS-DS-20)

Source Yao et al., 2020 · Department of Radiation Oncology, Fudan University Shanghai Cancer Center · DOI

Duration: 45 days Cell source: Patient-Derived iPSC (Locally Advanced Rectal Cancer) Full SOP · 8 phases · QC included
Drug screening
GS-DS-20 Full SOP with Academic or a plan